期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

原发性骨髓纤维化预后的研究进展 被引量：5

原文传递
导出
摘要 原发性骨髓纤维化的预后具有明显的异质性。由于国际预后积分系统和动态的国际预后积分系统等的提出，使得对该病的预后判断更为准确，据此制定患者的治疗策略也更趋合理。随着细胞和分子遗传学研究的不断深入，一些新的重要的预后因素也得以不断地确认。笔者就该领域的研究现况进行综述。
作者 徐俊卿(综述) 徐泽锋(审校) 肖志坚(审校)
机构地区 中国医学科学院、北京协和医学院、血液学研究所、血液病医院
出处 《国际输血及血液学杂志》 CAS 2012年第5期454-458,共5页 International Journal of Blood Transfusion and Hematology
基金 天津市自然科学基金重点项目（12JCZDJC23900）,卫生公益性行业科研专项经费项目（201202017）
关键词 原发性骨髓纤维化 预后因素 预后积分系统
分类号 R551.3 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献28

  • 1Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic mye|oid metaplasia., a report on 195 cases with a new scoring system. Blood, 1996,88(3) : 1013-1018.
  • 2Tefferi A, Huang J, Schwager S,et al. Validation and comparison of contemporary prognostic models in primary myelofibrosis.. analysis based on 334 patients from a single institution. Cancer, 2007, 109(10) : 2083-2088.
  • 3Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood,2009,113(13):2895-2901.
  • 4Cervantes F, Pereira A, Esteve J,et al. Identification of 'short- lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis. Br J Haematol, 1997,97(3) : 635-640.
  • 5Cervantes F, Barosi G, Demory JL, et al. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol, 1998,102 ( 3 ) : 684-690.
  • 6Kvasnicka HM, Thiele J, Werden C,et al. Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer, 1997, 80 ( 4 ) : 708-719.
  • 7Patnaik MM, Caramazza D, Gangat N, et al. Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival. Eur J Haematol, 2010, 84(2): 105-108.
  • 8Elliott MA, Verstovsek S, Dingli D, et al. Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis. Leuk Res, 2007,31(11): 1503-1509.
  • 9Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood, 2010,115(9) : 1703-1708.
  • 10Tefferi A, Siragusa S, Hussein K, et al. Transfusion dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis -prognostic relevance is independent of IPSS or karyotype. Am J Hematol,2010, 85(1) :14-17.

同被引文献38

  • 1金玉青,洪远林,李建蕊,李曦,王晓晓,吕光华.川芎的化学成分及药理作用研究进展[J].中药与临床,2013,4(3):44-48. 被引量：384
  • 2潘磊,陈培丰.清热解毒中药抗肿瘤作用机理研究进展[J].中华中医药学刊,2007,25(3):569-571. 被引量：65
  • 3Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment [ J ]. Blood, 2009, 113 ( 13 ) : 2895-2901.
  • 4Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) [J]. Blood, 2010, 115(5):1703-1708.
  • 5Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined Dynamic International Prognosis Scoring System for primary myelofibrosis that incorporate prognostic information from karyotype, platelet count, and transfusion status [J]. J Clin Oncol, 2011, 29(4):392-397.
  • 6Xu Z, Gale RP, Zhang Y, et al. Unique features of primary myelofibrosis in Chinese[J]. Blood, 2012, 119( 11 ):2469-2473.
  • 7Hussein K, Huang J, Lasho T, et al. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis[ J]. Eur J Haematol, 2009, 82(4):255-259.
  • 8Tefferi A, Mesa RA, Schroeder G, et al. Cytogenefic findings and their clinical relevance in myelofibrosis with myeloid metaplasia [ J ]. Br J Haematol, 2001, 113 (3) :763 -771.
  • 9Caramazza D, Begna KH, Gangat N, et al. Refined cytogenetic- risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients [J]. Leukemia, 2011, 25 ( 1 ) :82-88.
  • 10Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic rnyeloid metaplasia: a report on 195 cases with a new scoring system[J]. Blood, 1996, 88(3):1013-1018.

引证文献5

二级引证文献13

国际输血及血液学杂志
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部